Literature DB >> 23583329

Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria.

Irina V Perevoshchikova1, Casey L Quinlan2, Adam L Orr2, Akos A Gerencser2, Martin D Brand2.   

Abstract

H2O2 production by skeletal muscle mitochondria oxidizing palmitoylcarnitine was examined under two conditions: the absence of respiratory chain inhibitors and the presence of myxothiazol to inhibit complex III. Without inhibitors, respiration and H2O2 production were low unless carnitine or malate was added to limit acetyl-CoA accumulation. With palmitoylcarnitine alone, H2O2 production was dominated by complex II (44% from site IIF in the forward reaction); the remainder was mostly from complex I (34%, superoxide from site IF). With added carnitine, H2O2 production was about equally shared between complexes I, II, and III. With added malate, it was 75% from complex III (superoxide from site IIIQo) and 25% from site IF. Thus complex II (site IIF in the forward reaction) is a major source of H2O2 production during oxidation of palmitoylcarnitine ± carnitine. Under the second condition (myxothiazol present to keep ubiquinone reduced), the rates of H2O2 production were highest in the presence of palmitoylcarnitine ± carnitine and were dominated by complex II (site IIF in the reverse reaction). About half the rest was from site IF, but a significant portion, ∼40pmol H2O2·min(-1)·mg protein(-1), was not from complex I, II, or III and was attributed to the proteins of β-oxidation (electron-transferring flavoprotein (ETF) and ETF-ubiquinone oxidoreductase). The maximum rate from the ETF system was ∼200pmol H2O2·min(-1)·mg protein(-1) under conditions of compromised antioxidant defense and reduced ubiquinone pool. Thus complex II and the ETF system both contribute to H2O2 productionduring fatty acid oxidation under appropriate conditions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complex I; Complex II; Complex III; ETF; ETFQOR; Electron transferring flavoprotein–ubiquinone oxidoreductase; Electron-transferring flavoprotein; Free radicals; Palmitate; Palmitoylcarnitine; ROS; Succinate dehydrogenase

Mesh:

Substances:

Year:  2013        PMID: 23583329      PMCID: PMC3871980          DOI: 10.1016/j.freeradbiomed.2013.04.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  68 in total

1.  Fluorometric measurement of reduced pyridine nucleotide in cellular and subcellular particles.

Authors:  R W ESTABROOK
Journal:  Anal Biochem       Date:  1962-09       Impact factor: 3.365

2.  Measurement of proton leak and electron leak in isolated mitochondria.

Authors:  Charles Affourtit; Casey L Quinlan; Martin D Brand
Journal:  Methods Mol Biol       Date:  2012

3.  Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions.

Authors:  Casey L Quinlan; Adam L Orr; Irina V Perevoshchikova; Jason R Treberg; Brian A Ackrell; Martin D Brand
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

4.  Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.

Authors:  J F Turrens; A Alexandre; A L Lehninger
Journal:  Arch Biochem Biophys       Date:  1985-03       Impact factor: 4.013

5.  Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age.

Authors:  R G Hansford; B A Hogue; V Mildaziene
Journal:  J Bioenerg Biomembr       Date:  1997-02       Impact factor: 2.945

6.  Reaction of electron-transfer flavoprotein ubiquinone oxidoreductase with the mitochondrial respiratory chain.

Authors:  F E Frerman
Journal:  Biochim Biophys Acta       Date:  1987-09-10

7.  Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).

Authors:  Hiroko Miyadera; Kazuro Shiomi; Hideaki Ui; Yuichi Yamaguchi; Rokuro Masuma; Hiroshi Tomoda; Hideto Miyoshi; Arihiro Osanai; Kiyoshi Kita; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

8.  A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase.

Authors:  Adam L Orr; Casey L Quinlan; Irina V Perevoshchikova; Martin D Brand
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

9.  Multiple Q-cycle bypass reactions at the Qo site of the cytochrome bc1 complex.

Authors:  Florian Muller; Antony R Crofts; David M Kramer
Journal:  Biochemistry       Date:  2002-06-25       Impact factor: 3.162

10.  Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle.

Authors:  Natalie Lefort; Brian Glancy; Benjamin Bowen; Wayne T Willis; Zachary Bailowitz; Elena A De Filippis; Colleen Brophy; Christian Meyer; Kurt Højlund; Zhengping Yi; Lawrence J Mandarino
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

View more
  41 in total

1.  Inhibitors of ROS production by the ubiquinone-binding site of mitochondrial complex I identified by chemical screening.

Authors:  Adam L Orr; Deepthi Ashok; Melissa R Sarantos; Tong Shi; Robert E Hughes; Martin D Brand
Journal:  Free Radic Biol Med       Date:  2013-08-27       Impact factor: 7.376

2.  Pyruvate dehydrogenase complex and nicotinamide nucleotide transhydrogenase constitute an energy-consuming redox circuit.

Authors:  Kelsey H Fisher-Wellman; Chien-Te Lin; Terence E Ryan; Lauren R Reese; Laura A A Gilliam; Brook L Cathey; Daniel S Lark; Cody D Smith; Deborah M Muoio; P Darrell Neufer
Journal:  Biochem J       Date:  2015-04-15       Impact factor: 3.857

3.  Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.

Authors:  Peter Schönfeld; Georg Reiser
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 4.  Mitochondrial remodeling: Rearranging, recycling, and reprogramming.

Authors:  Roberta A Gottlieb; Daniel Bernstein
Journal:  Cell Calcium       Date:  2016-04-20       Impact factor: 6.817

Review 5.  Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions.

Authors:  Hoi-Shan Wong; Pratiksha A Dighe; Vojtech Mezera; Pierre-Axel Monternier; Martin D Brand
Journal:  J Biol Chem       Date:  2017-08-24       Impact factor: 5.157

6.  MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice.

Authors:  Shilpak Bele; Shravan Babu Girada; Aramita Ray; Abhishek Gupta; Srinivas Oruganti; Phanithi Prakash Babu; Rahul Sr Rayalla; Shashi Vardhan Kalivendi; Ahamed Ibrahim; Vishwajeet Puri; Venkateswar Adalla; Madhumohan R Katika; Richard DiMarchi; Prasenjit Mitra
Journal:  Elife       Date:  2020-12-22       Impact factor: 8.140

Review 7.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.

Authors:  Peter Schönfeld; Lech Wojtczak
Journal:  J Lipid Res       Date:  2016-04-14       Impact factor: 5.922

8.  The determination and analysis of site-specific rates of mitochondrial reactive oxygen species production.

Authors:  Casey L Quinlan; Irina V Perevoschikova; Renata L S Goncalves; Martin Hey-Mogensen; Martin D Brand
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

9.  Sites of superoxide and hydrogen peroxide production by muscle mitochondria assessed ex vivo under conditions mimicking rest and exercise.

Authors:  Renata L S Goncalves; Casey L Quinlan; Irina V Perevoshchikova; Martin Hey-Mogensen; Martin D Brand
Journal:  J Biol Chem       Date:  2014-11-11       Impact factor: 5.157

10.  Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat.

Authors:  Blair E Warren; Phing-How Lou; Eliana Lucchinetti; Liyan Zhang; Alexander S Clanachan; Andreas Affolter; Martin Hersberger; Michael Zaugg; Hélène Lemieux
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.